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Elimination of apoptotic neurons without inflammation is crucial for brain tissue 
homeostasis, but the molecular mechanism has not been firmly established. Triggering 
receptor expressed on myeloid cells-2 (TREM2) is a recently identified innate immune 
receptor. Here, we show expression of TREM2 in microglia. TREM2 stimulation induced 
DAP12 phosphorylation, extracellular signal–regulated kinase phosphorylation, and 
cytoskeleton reorganization and increased phagocytosis. Knockdown of TREM2 in microglia 
inhibited phagocytosis of apoptotic neurons and increased gene transcription of tumor 
necrosis factor 
 
  
 
and nitric oxide synthase-2, whereas overexpression of TREM2 increased 
phagocytosis and decreased microglial proinflammatory responses. Thus, TREM2 deficiency 
results in impaired clearance of apoptotic neurons and inflammation that might be 
responsible for the brain degeneration observed in patients with polycystic lipomembranous 
osteodysplasia with sclerosing leukoencephalopathy/Nasu-Hakola disease.
 
Efficient removal of apoptotic cells during
development and daily tissue homeostasis is
essential in all multicellular organisms (1, 2).
Clearance of apoptotic cells by phagocytes usu-
ally proceeds without any signs of inflammation.
It has been demonstrated that apoptotic cells
signal to phagocytes to act immunosuppressively
(3, 4). In particular, macrophages that have in-
gested apoptotic cells inhibit proinflammatory
cytokine production such as release of TNF-
 
 
 
.
Furthermore, it was shown that the repression
of proinflammatory phagocytes is directly cou-
pled to the recognition of apoptotic cells (5,
6), but the molecular mechanism behind this
antiinflammatory effect remains obscure.
In the central nervous tissue clearance of
apoptotic cells has to be strictly controlled be-
cause inflammatory processes would be detri-
mental to the central nervous system (CNS;
reference 7). Dysregulated chronic innate im-
munity of the CNS is likely to induce neuro-
degeneration. In particular, it has been suggested
that inflammatory mediators of activated micro-
glia and brain macrophages including proin-
flammatory cytokines, metalloproteinases, and
nitric oxide are the primary cause of neurode-
generation and impaired regeneration during
chronic infections or autoimmune processes
(8–11).
Triggering receptor expressed on myeloid
cells-2 (TREM2) is a member of the innate
immune receptor TREM family (12). It is
expressed on the cell membrane of monocyte-
derived dendritic cells, osteoclasts, and micro-
glia (12, 13). It is associated with the signaling
molecule DAP12, and it was suggested that an
unknown TREM2 ligand results in the phos-
phorylation of the immunoreceptor tyrosine-
based activation motif (ITAM) in the cytoplas-
mic domain of DAP12 (12, 14). In dendritic
cells, TREM2/DAP12 signaling induced phos-
phorylation of the extracellular signal–regulated
kinase (ERK) and promoted up-regulation of
the CC chemokine receptor 7 (CCR7; refer-
ence 14). Recently, mutations in TREM2 and
DAP12 have been described in polycystic li-
pomembranous osteodysplasia with sclerosing
leukoencephalopathy (PLOSL)/Nasu-Hakola
disease patients (15–17). It has been demon-
strated that DAP12/TREM2 deficiency re-
sults in impaired osteoclast differentiation and
function (18, 19), but the mechanism of neuro-
degeneration in DAP12/TREM2 deficiency is
still unclear.
Here, we have analyzed microglial function
in response to TREM2 stimulation or after
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knockdown of TREM2. Unexpectedly, we observed that
TREM2 stimulation of microglia neither induces transcrip-
tion of inflammatory mediators nor up-regulates immunore-
ceptors involved in antigen presentation. However, TREM2
stimulation increased migratory and phagocytic activity of
microglia. Furthermore, TREM2 knockdown microglia
showed impaired clearance of apoptotic neurons and in-
creased gene transcription of TNF-
 
  
 
and nitric oxide syn-
thase-2 (NOS2). Overexpression of TREM2 in microglia
resulted in increased phagocytosis of apoptotic neurons and
decreased gene transcription of TNF-
 
 
 
, IL-1
 
 
 
, and NOS2.
These results demonstrate that TREM2 signaling participates
in clearance of apoptotic neurons and down-regulation of
inflammation to maintain the local immunosuppressive mi-
croenvironment in the CNS. Lack of TREM2 signaling in
microglia results in impaired clearance of apoptotic neurons
and inflammation.
 
RESULTS
Gene transcription and protein expression of 
TREM2 in microglia
 
Primary microglia were isolated and purified from postnatal
mouse brain tissue. Purity of microglial cultures was always
 
 
 
95% as determined by flow cytometry analysis with anti-
bodies directed against the marker protein CD11b (Mac1).
RNA was prepared from microglia, primary neurons, and
splenocytes and analyzed by RT-PCR. Gene transcripts for
TREM2 and DAP12 were detected in microglia and spleno-
cytes but not in neuronal cultures (Fig. 1 A). Protein expres-
sion of TREM2 was analyzed by immunohistochemistry
with a polyclonal antibody directed against TREM2. Ex-
pression of TREM2 was detected on isolated microglia
identified by double labeling with antibodies directed against
CD11b (Fig. 1 B). In total, 97.6 
 
  
 
2.4% (mean 
 
  
 
SEM) of
microglia showed staining for TREM2. No staining of
TREM2 was observed on neurons, astrocytes, or oligoden-
drocytes, which were double labeled by antibodies directed
against 
 
  
 
tubulin III, glial fibrillary acidic protein (GFAP),
and the O4 antigen, respectively (Fig. 1 B).
 
TREM2 stimulation does not stimulate microglial 
inflammatory cytokine gene transcription
 
To analyze TREM2 signaling and function of primary mi-
croglia, we applied lentiviral vectors to transduce microglial
cells. First, lentiviral vector expressing mouse TREM2 Flag
tagged at the extracellular domain (Flag epitope–tagged
TREM2 vector [fTREM2]), a GFP control vector (GFP1),
a DAP12 vector tagged at the intracellular domain with GFP
(DAP12-GFP), and a mutant DAP12 vector lacking the
ITAM motif and tagged intracellularly with GFP (dominant
negative DAP12[mtDAP12]-GFP vector) were used (Fig. 2
A). Western blotting was performed to confirm that stimula-
tion of fTREM2 induces phosphorylation of DAP12. The
293 cell line was cotransfected with fTREM2 plus DAP12-
GFP or fTREM2 plus mtDAP12-GFP. Cells were either
stimulated with antibody directed against the Flag epitope or
control antibody. Analysis of total protein lysates showed
that stimulation of fTREM2 induced tyrosine phosphoryla-
tion of the DAP12-GFP (Fig. 2 B). No phosphorylation of
DAP12 was detected under nonstimulated conditions or af-
ter cotransfection of the mutant DAP12. We then analyzed
the usage of the lentiviral vectors for transduction of primary
microglia. Lentiviral vectors were ideally suited to transfer
genetic material into microglia because the transduction effi-
ciency was regularly 
 
 
 
90% (Table I). We first asked whether
TREM2 signaling activates gene transcription of inflamma-
tory cytokines and mediators in microglia. Microglia were
lentivirally transduced with the fTREM2 vector or the GFP
control vector. Microglia were then either cultured on plates
coated with antibody directed against the Flag epitope or
control antibody. After 24, 48, and 72 h of TREM2 stimula-
tion, RNA was collected and analyzed by semiquantita-
Figure 1. Gene transcription and protein expression of TREM2 in 
primary microglia. (A) RT-PCR for TREM2, DAP12, and GAPDH was per-
formed from RNA of primary cultured microglia, neurons, and splenocytes. 
Gene transcripts of TREM2 and DAP12 were observed in microglia and 
weakly in splenocytes, but not in neurons. Molecular weight marker: 
100-bp ladder. (B) Immunohistochemistry of cultured neurons, astrocytes, 
oligodendrocytes, and microglial cells. The distinct cell types were identi-
fied by specific antibodies (green fluorescence) directed against   tubulin–III, 
GFAP, O4, and CD11b. Cells were double labeled (red fluorescence) with 
specific polyclonal antibodies directed against TREM2. Expression of 
TREM2 was detected on 97.6   2.4% (mean   SEM) of microglial cells 
identified by double labeling with CD11b. No expression of TREM2 was 
detected on neurons, astrocytes, or oligodendrocytes. Bars, 10  m. 
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tive RT-PCR. Semiquantitative RT-PCR analysis showed
TNF-
 
 
 
, IL-1
 
 
 
, and TGF-
 
  
 
gene transcription in nonstimu-
lated microglia at levels comparable to TREM2-stimulated
microglia at all analyzed time points (Fig. S1, available at
http://www.jem.org/cgi/content/full/jem.20041611/DC1).
No cytokine gene transcripts of NOS2, IFN-
 
 
 
, IL-10, and
IL-12p40 were detected in nonstimulated as well as
TREM2-stimulated microglia (Fig. S1). Because we could
not detect any difference in cytokine gene transcription by
ordinary RT-PCR, we performed real-time PCR of gene
transcripts for TNF-
 
 
 
, IL-1
 
 
 
, and TGF-
 
  
 
(Fig. S2). Again,
despite the highly sensitive real-time PCR, no difference in
the transcript levels for TNF-
 
 
 
, IL-1
 
 
 
, and TGF-
 
  
 
between
nonstimulated and TREM2-stimulated microglia was ob-
served (Fig. S2).
 
Cross-linking fTREM2 of transduced microglia stimulates 
expression of CCR7 and migration toward CC chemokine 
ligand (CCL)19 and CCL21
 
To determine whether TREM2 signaling might stimulate
antigen presentation or migratory capacity of microglia, we
examined cell surface expression of several immune recep-
tors by flow cytometry. Microglia were transduced with the
fTREM2 vector or the GFP1 control vector. The microglia
were then either cultured on plates coated with antibody di-
rected against the Flag epitope or control antibody. Cells
were collected after 72 h, immunolabeled with specific anti-
bodies, and analyzed by flow cytometry. Stimulation of
TREM2 signaling did not induce expression of MHC class
II or CD11c (Fig. 3 A). Furthermore, expression levels of
CD86 and CD36 were unaltered after stimulation of
TREM2. Only the chemokine receptor CCR7 was slightly
induced in microglia after stimulation of TREM2 (Fig. 3 A).
To determine any functional consequences of increased
CCR7 expression, a chemotaxis assay was performed. Mi-
croglial cells were stimulated via TREM2 and placed in a
two-chamber system. The number of microglial cells mi-
grating toward the chemokine ligands CCL19 and CCL21
was quantified (Fig. 3 B). Indeed, increased CCR7 expres-
sion after TREM2 stimulation had a strong functional im-
pact. In detail, the number of microglia migrating toward
CCL19 increased from 20.3 
 
  
 
0.9 (mean 
 
  
 
SEM) to 70.8 
 
 
 
6.8 and toward CCL21 increased from 18.0 
 
  
 
4.2 to 41.0 
 
 
 
3.8 (Fig. 3 B).
These results demonstrate that TREM2 stimulation does
not stimulate antigen presentation but up-regulates expres-
sion of the chemokine receptor CCR7 and supports chemo-
taxis towards the corresponding ligands CCL19 and CCL21.
 
Cross-linking fTREM2 of transduced microglia stimulates 
phagocytosis
 
One important microglial function is the removal and clear-
ance of apoptotic cells and debris. Because TREM2 is in-
volved in bone resorption of osteoclasts, we speculated that
TREM2 molecules of microglia might be involved in
phagocytosis. To investigate this hypothesis, we performed a
microsphere bead phagocytosis assay. Microglia isolated from
postnatal mouse brains were transduced with the fTREM2
lentiviral vector or the control lentiviral vector. The trans-
duced microglia were cultured for 24 h on plates coated
with either Flag-specific antibodies or control antibodies.
Microsphere beads were then added to the culture for 1 h,
and phagocytosis of the beads was analyzed by fluorescence
microscopy and flow cytometry. The fTREM2 microglia
showed increased phagocytosis of multiple microsphere
beads after cross-linking of TREM2 compared with micro-
glia transduced with the control vector (Fig. 4 A). Further-
Figure 2. Lentiviral vectors and phosphorylation of DAP12 after 
stimulation of TREM2. (A) Schematic drawing of lentiviral vectors for 
expression of fTREM2, GFP (GFP1), DAP12 tagged with GFP (DAP12-GFP), 
or mutant mtDAP12 tagged with GFP (mtDAP12-GFP). (B) Phosphorylated 
DAP12-GFP was detected after blotting with the antibody directed against 
tyrosine phosphate in fTREM2 plus DAP12-GFP–cotransfected cells and 
after cross-linking stimulation. DAP12-GFP or mtDAP12-GFP were de-
tected after reblotting with the antibody directed against GFP in the 
samples, respectively.
 
Table I.
 
Lentiviral transduction efficiency
 
Lentiviral vector
Transduction efficiency of microglia
(mean 
 
  
 
SEM)
 
fTREM2 94.70 
 
  
 
0.81
GFP 93.85 
 
  
 
0.82
fTREM2 1 GFP 91.30 
 
  
 
1.10
fTREM2 1 DAP12-GFP 90.74 
 
  
 
0.56
fTREM2 1 mtDAP12-GFP 90.44 
 
  
 
1.91
shTREM2 96.80 
 
  
 
1.20
shControl 92.15 
 
  
 
0.85
wTREM2 93.20 
 
  
 
1.20
GFP2 93.60 
 
  
 
0.30 
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more, the increased phagocytosis was dependent on stim-
ulation of TREM2 (Fig. 4 A). Phagocytosis of the red
fluorescent microsphere beads was quantified by flow cy-
tometry to determine the percentage of microglia that
phagocytosed two or more beads. After the cross-linking of
TREM2, the number of fTREM2-transduced microglia that
phagocytosed multiple beads increased by 35 
 
  
 
11% (mean 
 
 
 
SEM) compared with no cross-linking of TREM2 (Fig. 4
B). No change in phagocytosis was observed after the cross-
linking of TREM2 in control vector–transduced microglia
(Fig. 4 B). Next, we investigated whether increased phago-
cytosis after TREM2 stimulation is mediated via the adaptor
signaling molecule DAP12. Microglia were cotransduced
with the fTREM2 lentiviral vector and an mtDAP12 len-
tiviral vector or the control vector. Again, we observed very
high transduction efficiency showing cotransduction with
both vectors in 
 
 
 
90% of microglial cells (Table I). When the
microglia were cotransduced with mtDAP12, stimulation of
TREM2 failed to increase phagocytosis of microsphere
beads (Fig. 4 C). No change of phagocytosis was observed
for cotransduced fTREM2 and mtDAP12 microglia be-
tween the TREM2-stimulated and nonstimulated condition
(Fig. 4 C). However, cotransduction of fTREM2 and the
GFP control vector showed up-regulation of microglial
phagocytosis by 29.1 
 
  
 
11.6% (mean 
 
  
 
SEM) after TREM2
stimulation compared with nonstimulated cells (Fig. 4 C).
This result demonstrated that TREM2 signaling increased
Figure 3. TREM2 stimulation up-regulates CCR7 and increases 
migration of microglia toward CCL19 and CCL21. Primary murine 
microglia were transduced with fTREM2 or GFP control vector. Microglia 
were cultured on dishes coated with cross-linking antibody directed 
against the Flag epitope ( ) or a control antibody ( ). (A) Primary micro-
glia were transduced with fTREM2 or GFP control vector and cultured on 
dishes coated with cross-linking antibody directed against the Flag 
epitope (red line) or control antibody (blue line) for 72 h. Cells were ana-
lyzed by flow cytometry after staining by specific antibodies directed 
against MHC class II, CD86, CD11c, CD36, and CCR7. Staining of cells with 
an isotype control antibody was performed (gray filled). A slight increase 
in CCR7 expression was observed in fTREM2-transduced microglia after 
stimulation of TREM2, which was not detected in the control vector–
transduced microglia. (B) TREM2 stimulation directs migration of microglia 
toward the CCR7 ligands CCL19 and CCL21. fTREM2-transduced microglia 
stimulated for 24 h with precoated 10  g/ml antibody directed against 
the Flag epitope (white bars), 10  g/ml isotype control antibody (black 
bars), or LPS (gray bars) were tested in transwell chemotaxis assays for 
their ability to migrate toward medium alone or medium supplemented 
with CCL19 or CCL21. Microglia showed increased migration toward 
CCL19 and CCL21. *, P   0.05; Mann-Whitney U test.
Figure 4. Increased bead phagocytosis after stimulation of TREM2. 
(A) Primary murine microglia were transduced either with fTREM2 vector 
(fTREM2) or GFP1 control vector. Microglia were cultured on dishes coated 
with antibodies directed against the Flag epitope to cross-link the fTREM2 
or control antibodies. Microglia were stimulated with antibodies for 24 h. 
Microsphere beads were then added for 1 h. Phase contrast images are 
shown, demonstrating visible phagocytosis of microshpere beads after 
stimulation of fTREM2-transduced microglia by cross-linking antibodies. 
Bars, 10  m. (B) Phagocytosis was quantified by flow cytometry. The rela-
tive change in bead phagocytosis after fTREM2 stimulation was compared 
with nonstimulated bead phagocytosis. Microglia transduced with fTREM2 
showed a significant increase in bead phagocytosis after cross-link stimu-
lation, whereas no significant change in bead phagocytosis was observed 
in GFP1-transduced microglia after cross-link stimulation. Data are presented 
as mean   SEM of at least three independent experiments. *, P   0.05; 
Mann-Whitney U test. (C) The relative change in bead phagocytosis after 
fTREM2 stimulation compared with the nonstimulated situation by flow 
cytometry. Microglia was transduced with fTREM2 plus GIP  or fTREM2 
plus mutant DAP12 (mtDAP12-GFP). The mtDAP12 transduction pre-
vented the increase in bead phagocytosis after fTREM2 stimulation. Data 
are presented as mean   SEM of at least three independent experi-
ments. *, P   0.01; Mann-Whitney U test. 
JEM VOL. 201, February 21, 2005
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phagocytosis of microsphere beads via DAP12 adaptor mole-
cule signaling.
 
Cross-linking fTREM2 of transduced microglia leads to 
reorganization of F-actin and phosphorylation of ERK
 
Phagocytosis requires kinase signaling and reorganization of
actin cytoskeleton. We analyzed whether TREM2 stimula-
tion might induce actin cytoskeleton reorganization in mi-
croglia. Therefore, microglia transduced with the fTREM2
vector were added to culture plates coated with the Flag-
specific antibody or control antibody. Cells were fixed after
1 h and F-actin was labeled with a fluorescence dye. Serial
confocal images demonstrated F-actin staining exactly at the
site of TREM2 stimulation (Fig. 5 A). In total, 72.5 
 
  
 
2.5%
(mean 
 
  
 
SEM) of microglia showed polarized F-actin stain-
ing at the site of TREM2 stimulation (Fig. 5 B). Thus, cross-
linking of TREM2 induced polarization and reorganization
of F-actin in microglia as a first sign of phagocytosis (Fig. 5,
A and B). Because TREM2/DAP12 signaling induced ERK
phosphorylation in immature dendritic cells, we analyzed
phosphorylation of ERK after cross-linking stimulation of
fTREM2 transduced microglia by Western blotting. Stimu-
lation of TREM2 of microglia induced phosphorylation of
ERK as demonstrated by a specific antibody recognizing
the phosphorylated form of ERK (Fig. 5 C). To determine
the involvement of ERK signaling in increased phagocyto-
sis, the microglia were pretreated with the ERK inhibitor
PD98059. Indeed, increased bead phagocytosis after TREM2
stimulation was neutralized by treatment with the ERK in-
hibitor (Fig. 5 D).
 
TREM2 expression of microglia determines phagocytosis of 
apoptotic neurons
 
Up-regulation of phagocytosis without induction of inflam-
matory cytokines and cytotoxic mediators implies clearance
without an inflammatory reaction. Because microglia play
an important role in the removal of apoptotic neurons dur-
ing development and aging, TREM2 might recognize ap-
optotic neuronal membranes and participate in their clear-
ance. To study the pathophysiological function of TREM2,
we used a lentiviral strategy to either knock down TREM2
by RNA interference or to overexpress TREM2 (Fig. 6).
Microglia were transduced with a lentiviral vector express-
ing either short hairpin TREM2 (shTREM2) RNA, a con-
trol vector that expressed a short hairpin scrambled se-
quence of TREM2 (short hairpin control [shControl]),
wild-type TREM2 (wTREM2) to overexpress the recep-
tor, or GFP as a control (GFP2). To confirm knockdown of
TREM2 gene transcripts, microglial RNA was analyzed at
72 h after transduction with the lentiviral RNA interference
vector. Indeed, no gene transcripts for TREM2 were de-
tected after 40 PCR cycles in reverse-transcribed RNA of
microglia after knockdown of TREM2 (Fig. 7 A). The
control vectors did not knock down TREM2. Immuno-
histochemistry was performed to confirm absence of TREM2
expression on microglia after knockdown. Although TREM2
was detected by specific antibodies on control vector–trans-
duced microglia, no expression of TREM2 was observed
after transduction of the microglia by the shTREM2 vec-
tor (Fig. 7 B). Again, transduction efficiency was always
 
 
 
92%, leading to a loss of TREM2 in almost all micro-
glial cells after transduction with the shTREM2 vector
(Table I). Flow cytometry analysis of microglia transduced
with shTREM2 by polyclonal antibodies directed against
TREM2 confirmed knockdown of TREM2, and it dem-
onstrated increased levels of TREM2 expression after trans-
Figure 5. Cytoskeleton reorganization and ERK signaling after 
stimulation of microglial phagocytosis by TREM2 cross-linking. 
(A) Primary murine microglia were transduced with fTREM2 vector. Micro-
glia were cultured on dishes coated with antibodies directed against the 
Flag epitope ( ) to cross-link the fTREM2 or control antibodies ( ) for 1 h. 
Microglia were fixed and then stained with Alexa Fluor 546–conjugated 
phalloidin. Individual microglial cells were scanned by a confocal micro-
scope from top (TOP) to bottom (BOTTOM) with a step of 1.6  m between 
each optical section. Strong F-actin staining was observed at the bottom 
of the cells after TREM2 stimulation. Phase contrast and confocal images 
are shown. Bars, 10  m. (B) Cytoskeleton reorganization of F-actin was 
quantified by counting the number of cells showing F-actin at the bottom 
of the cells. Data are presented as mean   SEM. (C) Western blot analysis 
of protein lysates of primary microglial cells. Phosphorylated ERK was de-
tected after blotting with a specific antibody directed against phosphory-
lated ERK in fTREM2-transfected cells after stimulation with a cross-linking 
antibody ( ), but not the control antibody ( ). The total protein amount 
of ERK was detected after reblotting with an antibody directed against total 
ERK. (D) Increased bead phagocytosis after fTREM2 stimulation is neutral-
ized by ERK inhibitor. The relative change in bead phagocytosis after 
fTREM2 stimulation was compared between the stimulated (open bars) 
and nonstimulated (closed bars) situation by flow cytometry. Microglia 
were transduced with fTREM2 vector and treated with or without ERK in-
hibitor. ERK inhibitor reverted the increase of phagocytosis stimulated by 
TREM2. Data are presented as mean   SEM of at least three independent 
experiments. *, P   0.05; Mann-Whitney U test. 
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duction of microglia with the vector wTREM2 to overex-
press TREM2 (Fig. 7 C).
Phagocytosis of apoptotic neurons by microglia was an-
alyzed after knockdown or overexpression of TREM2.
Neurons were labeled by a red fluorescent membrane dye
and pretreated with okaidic acid to induce apoptosis. Mi-
croglia transduced with the control vector (shControl)
phagocytosed the red fluorescent–labeled apoptotic neu-
ronal membranes within 1 h (Fig. 8, A and C). However,
phagocytosis of apoptotic membrane fragments was barely
detected under the fluorescence microscope after 1 h, when
the TREM2 receptor was knocked down in microglia
(Fig. 8 B). The number of microglia having phagocytosed
membrane material derived from apoptotic neurons was
quantified by flow cytometry. In detail, only 9.5 
 
  
 
1.6%
(mean 
 
  
 
SEM) of microglia showed phagocytosed neu-
ronal material after knockdown of TREM2, whereas 22.2 
 
 
 
2.4% of microglia transduced with the control vector
showed phagocytosis. Even after 24 h, only 11.9 
 
  
 
1.5%
of microglia phagocytosed apoptotic neuronal material if
TREM2 was knocked down (Fig. 8 D). Next, we analyzed
whether the mtDAP12 impairs phagocytosis of microglia.
After transduction of mtDAP12, phagocytosis of apoptotic
neuronal membranes was reduced from 24.5 
 
  
 
0.9% to 8.0 
 
 
 
1.8% (Fig. 8 D). Interestingly, overexpression of TREM2
increased phagocytosis of apoptotic neuronal material. In
total, 31.8 
 
  
 
2.2% (mean 
 
  
 
SEM) of microglia showed
phagocytosis of apoptotic neuronal material after overex-
pression of TREM2, whereas only 19.4 
 
  
 
1.3% of micro-
glia transduced with the control vector showed phagocyto-
sis (Fig. 8 D).
 
TREM2 determines gene transcription of inflammatory 
mediators during phagocytosis of apoptotic neurons
 
After having demonstrated that TREM2 knockdown microglia
showed reduced phagocytosis and TREM2 overexpressing mi-
croglia showed increased phagocytosis compared with control
vector–transduced microglia, we asked whether the impaired
phagocytosis is associated with a dysregulated cytokine tran-
scription. To study this question, we investigated gene tran-
scripts of proinflammatory cytokines and mediators in microglia
cocultured together for 48 h with apoptotic neuronal cells.
Figure 6. Schematic drawing of lentiviral vectors for knocking 
down TREM2 (shTREM2), shControl vector, wTREM2 vector, and 
GFP control vector (GFP2).
Figure 7. Knockdown and overexpression of TREM2 receptors in 
microglia by lentiviral vectors. (A) Gene transcript analysis of cultured 
microglia transduced with the shTREM2, shControl, wTREM2, or GFP2 vec-
tor. Gene transcripts for TREM2 and GAPDH were analyzed by RT-PCR. The 
lentiviral vector producing short hairpin RNAs specific for TREM2 induced 
complete knockdown of TREM2 gene transcripts. Gene transcripts for 
GAPDH and DAP12 served as an internal control and were not affected by 
the shTREM2 vector. Molecular weight marker: 100-bp ladder. (B) Protein 
expression of TREM2 was analyzed by a polyclonal antibody directed 
against TREM2 of cultured microglia transduced with the shTREM2 or 
shControl vector. Expression of TREM2 was not detectable by immunohis-
tochemistry in microglia transduced with the shTREM2 vector. Bars, 20  m. 
(C) Flow cytometry analysis of cultured microglial cells transduced either 
with a lentiviral vector producing short hairpin RNAs specific for TREM2 
(shTREM2), irrelevant short hairpin RNAs (shControl), wTREM2, or control 
GFP (GFP2). shTREM2 transduction expression of TREM2 was almost unde-
tectable, whereas wTREM2 transduction increased levels of TREM2 expres-
sion on microglia. 
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Gene transcripts for TNF-
 
 
 
, IL-1
 
 
 
, TGF-
 
 
 
, and NOS2
were detected in the cultured cells and quantified by real-
time PCR (Fig. 9). Gene transcripts for IL-12p40 were only
detected in microglia after knockdown of TREM2, but no
other samples (not depicted). No gene transcripts of IFN-
 
 
 
and IL-10 were detected in any experimental group. Knock-
down of TREM2 in microglia increased the relative level of
TNF-
 
  
 
from 1 to 1.9 
 
  
 
0.3 (mean 
 
  
 
SEM), of IL-1
 
 
 
 to
1.3 
 
  
 
0.3, and of NOS2 to 1.8 
 
  0.5 compared with the sh-
Control-transduced microglia. In contrast, overexpression of
TREM2 in microglia reduced the relative level of inflamma-
tory gene transcripts after 48 h of coculture with apop-
totic  neurons. In detail, microglia cells transduced with
wTREM2 showed a reduction of relative gene transcript
levels for TNF-  from 1 to 0.7   0.1 (mean   SEM), for
IL-1  to 0.6   0.2 SEM, and for NOS2 to 0.4   0.2 (Fig. 9).
Gene transcript levels of TGF-  were not modulated by
knockdown or overexpression of TREM2. Surprisingly, ex-
pression of mtDAP12 in microglia did not change the rela-
tive level of TNF- , IL-1 , TGF- , or NOS2 gene tran-
scripts. Thus, gene transcripts of microglial inflammatory
mediators were significantly modulated by the presence or
absence of TREM2 on microglia and even by the level of
TREM2 expression.
DISCUSSION
Gene transfer into primary cultured microglia or macro-
phages by classical transfection procedures is very poor and
results in very low transfection efficiency (20). We applied
vesicular stomatitis virus glycoprotein–pseudotyped lentiviral
vectors to transduce primary microglia. Transduction effi-
ciency was very high ( 90%). The expression was stable and
transduction was reproducible. Furthermore, lentiviral vec-
tors were successfully used for specific knockdown of gene
transcripts by small hairpin RNAs. RNA interference for
TREM2 by lentiviral small hairpin RNAs reduced TREM2
gene transcripts to levels undetectable by 40 cycles of RT-
PCR, whereas the gene transcripts of GAPDH or DAP12
were not affected. Knockdown of TREM2 in microglia by
RNA interference allowed us to study the role of TREM2 in
mature and differentiated microglia. Although we have not
observed any effect of the transduction procedure or the ex-
pression of nonrelated small hairpin RNAs in our control ex-
Figure 8. TREM2 expression of microglia determines phagocytosis 
of apoptotic neuronal membranes. Cultured neurons were labeled with 
a red fluorescent membrane dye, treated with okadaic acid to induce 
apoptosis, and cocultured with microglia transduced either with a lentiviral 
vector producing short hairpin RNAs specific for TREM2 (shTREM2), irrele-
vant short hairpin RNAs (shControl), wTREM2, control GFP2 vector, 
mtDAP12 (mtDAP12-GFP), or control GFP1 vector. Cells were analyzed by 
fluorescence microscopy and flow cytometry. (A) Microglia (green fluorescent 
protein) lentivirally transduced with the control vector (shControl) phago-
cytosed apoptotic neuronal membrane fragments (red fluorescent dye) as 
shown by confocal images. Inset as indicated. Bar, 10  m. (B) No obvious 
phagocytosis was observed in TREM2 knockdown microglia. Bar, 10  m. 
(C) High magnification of the shControl image. Bar, 10  m. (D) The per-
centage of cells having phagocytosed apoptotic neuronal membrane frag-
ments was quantified by flow cytometry at 1 and 24 h of coculture. Micro-
glia were transduced with lentiviral vectors producing short hairpin RNAs 
specific for TREM2 (shTREM2), irrelevant short hairpin RNAs (shControl), 
wTREM2, control GFP2, mtDAP12 (mtDAP12-GFP), or control GFP1. 
wTREM2 vector (wTREM2)-transduced microglia phagocytosed signifi-
cantly more apoptotic neuronal material after 1 and 24 h compared with 
GFP- (GFP1 or GFP2) or control vector (shControl)-transduced microglia. 
Control vector (shControl)- and GFP (GFP1 or GFP2)-transduced microglia 
phagocytosed more apoptotic neuronal material after 1 and 24 h com-
pared with microglia transduced with the TREM2 knockdown (shTREM2) 
or mtDAP12 (mtDAP12-GFP) vector. Data are presented as mean   SEM. 
*, P   0.02; **, P   0.05; ***, P   0.01; Mann-Whitney U test.
Figure 9. TREM2 expression determines inflammatory response of 
microglia during phagocytosis of apoptotic neuronal material. Gene 
transcription of inflammatory mediators was analyzed by real-time RT-PCR 
of microglia cocultured with apoptotic neurons. Microglia were transduced 
with lentiviral vectors producing short hairpin RNAs specific for TREM2 
(shTREM2), irrelevant short hairpin RNAs (shControl), wTREM2, control 
GFP2, mtDAP12 (mtDAP12-GFP), or control GFP1 vector. Relative level of 
gene transcripts for TNF- , IL-1 , and NOS2 were increased in microglia 
transduced with the TREM2 knockdown vector compared with the control 
vector and decreased in microglia-overexpressing TREM2 compared with 
the control vector. Data are presented as mean   SEM. *, P   0.02; Mann-
Whitney U test.CLEARANCE OF APOPTOTIC NEURONS BY MICROGLIAL TREM2 | Takahashi et al. 654
periments, we cannot completely exclude that the lentiviral
transduction procedure per se might influence the phenotype
of microglia.
Function of TREM2 has been studied before in den-
dritic cells and osteoclasts. When immature human dendritic
cells were stimulated by a cross-linking monoclonal antibody
directed against human TREM2, MHC class II and the co-
stimulatory CD86 and CD40 molecules were up-regulated
(14). Moreover, TREM2 stimulation of immature dendritic
cells strongly induced expression of CCR7, a chemokine
receptor binding the ligands CCL19 and CCL21 (14). In
contrast, in our study we observed that TREM2 signaling of
microglial cells neither stimulated MHC class II nor
costimulatory molecules. Only an up-regulation of CCR7
was observed after triggering TREM2 in microglia. The up-
regulation of CCR7 after TREM2 stimulation appeared to
be functional because the TREM2-stimulated microglia
showed increased chemotaxis toward CCL19 and CCL21,
the ligands of CCR7. Furthermore, in our study the effect of
TREM2 stimulation on microglia was relatively selective for
phagocytosis, indicating that TREM2 might activate intra-
cellular pathways distinct from other innate immune recep-
tors. Phagocytosis has been shown to require actin cytoskel-
eton reorganization (21) and kinase signaling (22). We
observed that TREM2 stimulation induced polarization of
F-actin and ERK/MAPK phosphorylation, but not phos-
phatidylinositol 3-kinase (PI3K) signaling (not depicted). In
this respect, microglia behave like dendritic cells, where it
was shown that TREM2 stimulates ERK, but not PI3K sig-
naling (14). There are several similarities between TREM2
receptor and Toll-like receptors. Both Toll-like receptors
and TREM2 receptor are innate immune receptors involved
in phagocytosis (23) and actin remodeling (24). However,
TREM2 stimulates phagocytosis without inflammation, whereas
Toll-like receptor–mediated signaling is known to activate
NF- B and inflammatory cytokine gene transcription. Inter-
estingly, in dendritic cells, TREM2 stimulation was also in-
dependent of NF- B activity (14).
Recently, it was demonstrated that DAP12/TREM2 de-
ficiency results in impaired and delayed osteoclast differenti-
ation with a reduced bone resorption capability in vitro (18,
19). Principally, this observed defect in bone resorption
could be due to impaired phagocytosis, although no direct
evidence has been provided for this mechanism in osteo-
clasts. We now have shown impaired phagocytosis of apop-
totic neurons after knockdown of TREM2 in microglia.
A recent publication suggested that microglia as well as
oligodendrocytes express DAP12 molecules, which might
participate in myelin loss and neurodegeneration of DAP12
mutant mice (25). In our immunohistochemistry analysis,
we did not detect TREM2 expression in oligodendrocytes
and found TREM2 expression solely on microglia and no
other brain cell types. Furthermore, we demonstrated in this
study that intact signaling via DAP12 in microglia is required
for increasing phagocytic activity after TREM2 stimula-
tion. Furthermore, we demonstrate here that expression of
mtDAP12 in microglia impairs phagocytosis of apoptotic
neurons. PLOSL, also named Nasu-Hakola, is a recessively
inherited disease due to functional deficiency of TREM2 or
DAP12 (16, 26). DAP12/KARAP has been shown to be in-
volved in dendritic cell function and development of au-
toimmunity (27–29). Clinically and histopathologically,
no difference has been described between patients with
TREM2 and DAP12 mutations. Thus, our data suggest mi-
croglial impairment to be responsible for the CNS pheno-
type of PLOSL/Nasu-Hakola disease. Because no function
of DAP12 in oligodendrocytes has been described so far, it is
unclear whether loss of DAP12 function in oligodendrocytes
has any pathophysiological consequences.
Cells that die in a physiological context are typically re-
moved rapidly by phagocytic cells including macrophages
and microglia (1, 2). In contrast to removal of necrotic cells,
apoptotic cells are eliminated without inflammation or pa-
thology. Interestingly, lack of inflammatory responses associ-
ated with engulfment of apoptotic debris is more than a pas-
sive avoidance of stimulation. Apoptotic cells affirmatively
inhibit inflammatory responses and cytokine production in-
cluding TNF-  from the phagocytic cells that ingest them
(4). The ingestion of apoptotic cells even attenuates the stim-
ulatory response of the Toll-like receptor complex (5), dem-
onstrating that the inhibitory effect of apoptotic targets is
dominant in trans to the stimulatory effect of Toll-like recep-
tors (5). Furthermore, the inhibitory effect does not modulate
the NF- B activation by stimulation of the Toll-like recep-
tors via LPS (6). So far, the receptors that could signal this in-
hibitory effect remained unresolved. In this study, we found
that the TREM2 receptor fulfills most of the features of such
a postulated inhibitory receptor on phagocytic cells stimu-
lated by apoptotic cells. Particularly, TREM2 stimulation se-
lectively increased phagocytic activity without the stimula-
tion of cytokine production by microglia. More strikingly,
knockdown of TREM2 in microglia increased the gene tran-
scription of the proinflammatory mediators TNF-   and
NOS2 and induced gene transcription of IL12p40 after chal-
lenge of microglia with apoptotic neurons. Surprisingly, mi-
croglia with functionally impaired DAP12 signaling did not
change gene transcript level of proinflammatory mediators af-
ter challenge with apoptotic neurons. Thus, mtDAP12 might
interfere with additional DAP12-associated molecules.
In the nervous tissue, microglia have been shown to ex-
press TREM2 (13). It was speculated that microglia might
have a primary role in the pathogenesis of the CNS pheno-
type in PLOSL/Nasu-Hakola disease (12). The characteristic
hallmarks of PLOSL/Nasu-Hakola disease are neuropsychiat-
ric symptoms followed by neurodegeneration and cystic bone
lesions becoming symptomatic during dulthood. The patho-
logical changes lead to bone fractures and profound presenile
dementia and premature death. Interestingly, patients with
PLOSL/Nasu-Hakola disease show massive gliosis including
activated microglia in the CNS despite impaired ITAM sig-JEM VOL. 201, February 21, 2005 655
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naling via DAP12/TREM2. The TREM2 receptor signals
via DAP12, which contains ITAM signaling molecules that are
supposed to activate microglia. Thus, one would expect that
mutation of TREM2 or DAP12 leads to inactivation of mi-
croglia. Surprisingly, the opposite effect was observed. Our in
vitro results now demonstrate that TREM2 and DAP12 signal-
ing play an important role in the clearance of apoptotic neu-
rons. Furthermore, the data show that microglia with func-
tionally impaired TREM2 have increased gene transcription of
inflammatory mediators after confrontation with apoptotic neu-
rons. This allows us to suggest that TREM2 deficiency dys-
regulates microglial phagocytosis and release of inflammatory
mediators. Because neuronal cell death is a regular but relatively
rare event, the inflammatory lesions and the associated neuro-
degeneration might develop over several years in PLOSL pa-
tients and might be difficult to detect in the short life span of
the DAP12 mutant mice, which have synaptic degeneration,
myelin abnormalities, and microglial activation (25).
In summary, the data demonstrate that TREM2 and its
signaling molecule DAP12 of microglia are involved in
phagocytosis. Deficiency of TREM2 results in impaired up-
take of apoptotic neurons and increased production of in-
flammatory mediators. Thus, impaired microglia might in-
duce inflammatory lesions in PLOSL/Nasu-Hakola disease.
MATERIALS AND METHODS
Primary cell culture. Microglia were prepared from the brains of post-
natal day 3 to 5 (P3 to P5) C57BL/6 mice as described previously (30). In
brief, meninges were removed mechanically, and the cells were dissociated
by trituration and cultured in basal medium (BME; GIBCO BRL), 10%
FCS (PAN Biotech GmbH), 1% glucose (Sigma-Aldrich), 1% L-glutamine
(GIBCO BRL), and 1% penicillin/streptomycin (GIBCO BRL) for 14 d
to form a confluent glial monolayer. To collect microglial cells, the cul-
tures were shaken on a rotary shaker (200 rpm) for 2 h. The attached astro-
cytes were used for immunohistochemistry. The detached microglial cells
were seeded in normal culture dishes for 1 h, and then all nonadherent cells
were removed and discarded. Purity of the isolated microglia was  95% as
determined by flow cytometry analysis with antibody directed against
CD11b (BD Biosciences). Microglial cells were cultured in basal medium
as described above.
Oligodendrocytes and neuron-enriched cells were prepared from the
brain of C57BL/6 mouse embryos (E15-16) as previously described (31). In
brief, brain tissue was isolated and mechanically dispersed and seeded in cul-
ture dishes precoated with 0.01 mg/ml poly-L-ornithin (Sigma-Aldrich)
and 10  g/ml laminin (Sigma-Aldrich). Cells were cultured in neuronal
condition medium (BME; GIBCO BRL) supplemented with 2% B-27 sup-
plement (GIBCO BRL), 1% glucose (Sigma-Aldrich), and 1% FCS (PAN
Biotech GmbH). Cells were cultured for 5–10 d to obtain morphologically
mature neurons or oligodendrocytes.
RT-PCR analysis for TREM2 gene transcripts. RNA was isolated
from microglia, neuronal cultures, or splenocytes by the RNeasy Mini Kit
(QIAGEN). Reverse transcription of RNA was performed with Super-
Script III reverse transcriptase (Invitrogen) and hexamer random prim-
ers (Roche Molecular Biochemicals). For semiquantification, all samples
were normalized with GAPDH amplification. The following oligonu-
cleotides were used for PCR amplification: GAPDH forward: 5 -AAC-
TTTGGCATTGTGGAAGG-3 , reverse: 5 -ACACATTGGGGGTAG-
GAACA-3 ; TREM2 forward: 5 -ATGGGACCTCTCCACCAGTT-3 ,
reverse: 5 -TCACGTACCTCCGGGTCCA-3 ; and DAP12 forward: 5 -
ATGGGGGCTCTGGACCCCT-3 , reverse: 5 -TCATCTGTAATAT-
TGCCTCTGTGT.
Immunohistochemistry for TREM2. Isolated microglia and astrocytes
as well as neuronal cultures containing neurons and oligodendrocytes were
fixed in 4% paraformaldehyde for 1 h, blocked by 1% BSA/PBS for 2 h, and
then immunostained with a purified polyclonal rabbit antibody directed
against TREM2 (R&D Systems) and a secondary fluorescence Cy3-conju-
gated antibody directed against rabbit IgG (1:200; Dianova). To identify the
cell type, cells were double labeled with monoclonal mouse antibody di-
rected against   tubulin III (Sigma-Aldrich), GFAP (DakoCytomation), O4
(R&D Systems), and CD11b followed by a secondary fluorescence FITC-
conjugated antibody directed against mouse IgG. Images were collected by
confocal laser scanning microscopy with a 40  objective (Leica).
Lentivirus vector system and microglial transduction. Lentiviral
vectors of the third generation, PLL3.7 (provided by L. van Parijs, MIT,
Cambridge, MA) and pLenti6/V5 (Invitrogen), were used for the transduc-
tion of microglia. The mouse TREM2 gene was derived from reverse-tran-
scribed RNA obtained from primary cultured microglia and was tagged
three times at the NH2 terminus with the Flag epitope. fTREM2 and the
GFP gene (BD Biosciences) were cloned into the pLenti6/V5 vector. The
mouse DAP12 (provided by E. Vivier, Centre d’Immunologie, Marseille,
France) and deletion mutant mouse DAP12 (amino acids 1–88) were tagged
with the GFP gene and cloned into the pLenti6/V5 vector. The correct na-
ture of all cloned sequences was confirmed by automated sequencing (Seq-
lab) of the vectors. wTREM2 short hairpin RNA sequence (5 -TGA TGC
TGG AGA TCT CTG GGT TCA AGA GAC CCA GAG ATC TCC
AGC ATC TTT TTT C-3 ) and mutant-type mouse TREM2 short hairpin
RNA sequence for control study (5 -TGA TGC TGA AGG TCG CTT
GGT TCA AGA GAC CAA GCG ACC TCC AGC ATC TTT TTT
C-3 ) were inserted into the PLL3.7 vector as described by Rubinson et al.
(32). For overexpression of TREM2, we replaced the blastcidin resistance
gene in the pLenti6/V5 vector by the GFP gene under a second CMV pro-
moter and subcloned the wTREM2 gene under the first CMV promoter.
Lentiviral transduction was performed as described previously (32). In
brief, PLL3.7 or pLenti6/V5 vectors were purified and then cotransfected
together with packaging vectors (Invitrogen) into 293FT cells (Invitrogen).
Supernatant was collected after 48 h, and viral particles in the supernatant
were concentrated at 1:100 by ultracentrifugation for 90 min at 25,000 rpm
(SW28 rotor; Beckman Coulter) and recovered by suspension in PBS. Ti-
ters of viral particles ranged between 106 and 107 multiplicity of infection.
Purified microglia were seeded at 2   105 cells/ml into 24-well plates. Len-
tiviral particles and 8  g/ml polybrene (Sigma-Aldrich) were added to the
culture and centrifuged for 90 min at 30 C. Supernatant was removed im-
mediately after infection and replaced with BME medium containing 10%
FCS and 50% glial culture supernatant. In all experiments the efficiency of
microglia transduction was at least  90% as determined by the number of
microglia expressing the GFP molecule and by immunohistochemistry.
Western blot. For Western blotting, 293 cells (Invitrogen) were cotrans-
fected with the fTREM2 plus DAP12-GFP plasmids or the fTREM2 plus
mtDAP12-GFP plasmids. Cells were added to culture dishes coated with
the antibody directed against the Flag epitope or control antibody and
shortly centrifuged. After 10 min the cells were lysed, and the total protein
lysate was analyzed with antibody specific for tyrosine phosphate (4G10;
Upstate Biotechnology) by NuPAGE electrophoresis system (Invitrogen)
and ECL Advance Western Blotting Detection Kit (Amersham Bio-
sciences). In a second step, the membrane was reblotted with antibody di-
rected against GFP (BD Biosciences).
RT-PCR for analysis of inflammatory gene transcripts. Microglia
were transduced with the fTREM2 vector or the GFP1 (refer to Fig. 2)
control vector. Cells were then cultured on dishes and precoated with 10
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 g/ml isotype control antibody (Sigma-Aldrich). After 24, 48, and 72 h,
RNA was isolated from microglia by the RNeasy Mini Kit (QIAGEN).
RNA was also collected from microglia that have been transduced with
shTREM2, shControl, wTREM2, GFP2 (refer to Fig. 6), mtDAP12-GFP,
and GFP1 (refer to Fig. 2) vector and cocultured with apoptotic neurons for
48 h as described below. Reverse transcription of RNA was performed as
described above. Quantitative RT-PCR by SYBR Green was performed
on an ABI Prism 5700 Sequence Detection System (PerkinElmer). Amplifi-
cation of GAPDH was used for sample normalization. The amplification
protocol followed the GeneAmp 5700 Sequence Detection System Soft-
ware (version 1.3). For detection of GAPDH, TNF- , IL-1 , NOS2, and
TGF-  transcripts, the following forward and reverse primers were used at
final concentrations of 200 nM: GAPDH forward: 5 -CTCCACTCACG-
GCAAATTCAA-3 , reverse: 5 -GATGACAAGCTTCCCATTCTCG-
3 ; TNF-   forward: 5 -CCGTCAGCCGATTTGCTATCT-3 , reverse:
5 -ACGGCAGAGAGGAGGTTGACTT-3 ; IL-1   forward: 5 -ACAA-
CAAAAAAGCCTCGTGCTG-3 , reverse: 5 -CCATTGAGGTGGAGA-
GCTTTCA-3 ; NOS2 forward: 5 -GGCAAACCCAAGGTCTACG-
TTC-3 , reverse: 5 -TACCTCATTGGCCAGCTGCTT-3 ; and TGF- 1
forward: 5 -AGGACCTGGGTTGGAAGTGG-3 , reverse: 5 -AGTTG-
GCATGGTAGCCCTTG-3 .
Flow cytometry analysis. Microglia were transduced with the fTREM2
vector or the GFP control vector. Cells were then cross-linked as mentioned
above. After 72 h, microglia were first incubated for Fc receptor blockade by
CD16/CD32 antibody (BD Biosciences) and then stained with either
biotin-conjugated anti-CD11b, anti-CD11c, anti-CD86, anti–I-Ab, anti-
CD36 (BD Biosciences), or anti–mouse CCR7 (ALEXIS Corporation)
followed by CyChrome-conjugated streptavidin (BD Biosciences) or bio-
tin-conjugated anti–goat IgG and Cy5-conjugated streptavidin (Dianova).
Analysis was performed with a FACSCalibur flow cytometer (BD Bio-
sciences). Live gating was performed with propidium iodide (Sigma-Aldrich).
Microsphere bead phagocytosis assay. Microglia were transduced with
the fTREM2 vector or the GFP control vector, or cotransduced with the
fTREM2 and mtDAP12 vector or the fTREM2 and the GFP control vec-
tor. Cells were then cross-linked as mentioned above. After 24 h, 1.00  m
of red fluorescent microsphere beads (Fluoresbrite Polychromatic Red Mi-
crospheres; Polysciences Inc.) were added for 1 h. Phagocytosis of micro-
sphere beads by microglia was analyzed by fluorescence microscopy. Fur-
thermore, microglia were collected from the culture plates and analyzed by
flow cytometry. The percentage of microglia having phagocytosed beads
was determined. Because phagocytosis varied from one experiment to the
other, the relative change in phagocytosis was determined. Data are shown
as the relative change in phagocytosis between microglia cultured on anti-
body directed against the Flag epitope and control antibody.
Reorganization of the actin cytoskeleton. Microglia were transduced
with the fTREM2 vector. Cells were then cross-linked for 1 h as men-
tioned above. Cells were fixed, blocked, and then stained with Alexa Fluor
546–conjugated phalloidin (Molecular Probes). Images were collected by
confocal laser scanning microscopy with a 40  objective (Leica).
Pharmacological inhibition. In blocking experiments, 20  M ERK in-
hibitor PD98059 and 10  M PI3K inhibitor LY294002 (both from Calbio-
chem) were added 60 min before stimulation of TREM2.
Chemotaxis assay. Microglia were transduced with the fTREM2 vector.
Cells were then cross-linked for 24 h as mentioned above and treated with
1  g/ml LPS as indicated in Fig. 3. Microglia were transferred into the up-
per chamber of a transwell system (3- m pore filter; Millipore) containing
450  l medium with 100 ng/ml CCL19 or CCL21 (both from PeproTech)
in the lower chamber. After a 1-h incubation period, the number of micro-
glia that had migrated to the lower chamber was counted in three indepen-
dent areas by microscopy.
Western blot analysis of ERK activation. Microglia were transduced
with fTREM2 vector and 2   105 cells were then cross-linked for 1 h as
mentioned above. After stimulation, cells were lysed in reducing sample
buffer for Western blot analysis. Phosphorylation of ERK and total amount
of ERK were determined by immunodetection with anti–phospho-ERK and
anti-ERK antibodies, respectively (both from Cell Signaling Technology).
Phagocytosis assay of apoptotic neurons. Microglia were transduced
with shTREM2, shControl, wTREM2, GFP1 control (refer to Fig. 2),
mtDAP12-GFP, and GFP2 control (refer to Fig. 6) vector. After transduc-
tion, microglia were cultured for 72 h to achieve effective knockdown of
TREM2 by RNA interference. Neurons were cultured for 5–10 d, and
okadaic acid was then added at the final concentration of 30 nM for 3 h to
induce apoptosis. Neuronal cell membranes were labeled with CellTracker
CM-DiI membrane dye (Molecular Probes). After incubation, apoptotic
neurons were washed two times and added to the transduced microglial cul-
ture at an effector/target ratio of 1:20. At 1 and 24 h after addition of apop-
totic neurons, the number of microglia having phagocytosed neuronal cell
membranes were counted under a confocal fluorescence microscope (Le-
ica). Apoptotic cells were counted in three different areas at a magnification
of 60. The amount of phagocytosis was confirmed by flow cytometry.
Moreover, 24, 48, or 72 h after the addition of apoptotic neurons, cells
were collected and used for RT-PCR of cytokines.
Statistical analysis. Data are presented as mean   SEM of at least three
independent experiments. Data were analyzed by the Mann-Whitney U
test to determine significant differences.
Online supplemental material. Gene transcripts of TNF- , IL-1 ,
TGF- , NOS2, IFN- , IL-12p40, IL-10, and GAPDH were analyzed by
semiquantitative and real-time RT-PCR. Figs. S1 and S2 are available at
http://www.jem.org/cgi/content/full/jem.20041611/DC1.
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